Cargando…
Multi-Biomarkers Panel in Identifying Benign and Malignant Lung Diseases and Pathological Types of Lung Cancer
With the discovery of many tumor markers, there are new strategies for the early diagnosis and treatment of lung cancer and the prediction of prognosis. We examined the multi-protein markers panel (4MP, consisting of Pro-SFTPB, CA125, Cyfra21-1, and CEA) diagnosis performance in differentiating beni...
Autores principales: | Yao, Lige, Li, Yanli, Wang, Qin, Chen, Tian, Li, Jiayin, Wang, Yingjie, Zhang, Liuyan, Su, Li, Li, Lanqing, Lou, Qinqin, Li, Fang, Zhao, Jiali, Gao, Junli, Gao, Junshun, Li, Huiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355209/ https://www.ncbi.nlm.nih.gov/pubmed/37476198 http://dx.doi.org/10.7150/jca.85846 |
Ejemplares similares
-
Auxiliary diagnosis of Lung Cancer on the basis of a Serum Protein Biomarker Panel
por: Lu, Qiong, et al.
Publicado: (2021) -
MicroRNA-608 sensitizes non-small cell lung cancer cells to cisplatin by targeting TEAD2
por: Wang, Yanli, et al.
Publicado: (2019) -
A Rare Strain Actinomadura geliboluensis Was First Isolated from the Bronchoalveolar Lavage Fluid of a Patient with Pneumonia
por: Yu, Yefu, et al.
Publicado: (2023) -
A wavelet features derived radiomics nomogram for prediction of malignant and benign early-stage lung nodules
por: Jing, Rui, et al.
Publicado: (2021) -
A panel of four genes accurately differentiates benign from malignant thyroid nodules
por: Wang, Qing-Xuan, et al.
Publicado: (2016)